ClinicalTrials.Veeva

Menu

A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination

University of Maryland logo

University of Maryland

Status

Completed

Conditions

Anal Cancer
Penile Cancer
Cervical Cancer

Treatments

Behavioral: HPV vaccination messages

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03856437
1322177-1.1
R01CA219060 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in which they view either gain-framed or loss-framed HPV vaccination messages. Key outcome variables include parents' attitudes and intentions toward vaccinating their children against HPV.

Full description

The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants recruited from local communities and online panels will complete a computer-assisted survey. In the survey participants will first answer questions related to their beliefs about HPV and the HPV vaccine (e.g., perceived susceptibility, perceived severity, perceived efficacy, perceived safety, etc.), as well as other background information. Then they will be presented with either a gain-framed or loss-framed human papillomavirus vaccination message. After the message exposure, they will answer questions related to their attitudes toward HPV vaccination, intentions to vaccinate their children, as well as other message response measures. Eligible participants are at least 21 years old, self-identify as African American, and are custodial parents or caretakers of at least one child ages 9-17 who has not initiated the HPV vaccine series.

Enrollment

1,170 patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Self-identify as African American
  • Custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV.
  • Has access to Internet to complete the study

Exclusion criteria

  • Younger than 18 years
  • Does not self-identify as African American
  • Not a custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV.
  • Has no access to Internet to complete the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,170 participants in 3 patient groups

Gain-framed messages
Experimental group
Description:
Participants in this arm receive gain-framed HPV vaccination messages.
Treatment:
Behavioral: HPV vaccination messages
Loss-framed messages
Experimental group
Description:
Participants in this arm receive loss-framed HPV vaccination messages.
Treatment:
Behavioral: HPV vaccination messages
Control messages
Active Comparator group
Description:
Participants in this arm receive non-framed HPV vaccination messages.
Treatment:
Behavioral: HPV vaccination messages

Trial documents
3

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems